Claudin-2 expression is upregulated in the ileum of diarrhea predominant irritable bowel syndrome patients

被引:25
|
作者
Ishimoto, Haruka [1 ]
Oshima, Tadayuki [1 ]
Sei, Hiroo [1 ]
Yamasaki, Takahisa [1 ]
Kondo, Takashi [1 ]
Tozawa, Katsuyuki [1 ]
Tomita, Toshihiko [1 ]
Ohda, Yoshio [1 ]
Fukui, Hirokazu [1 ]
Watari, Jiro [1 ]
Miwa, Hiroto [1 ]
机构
[1] Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan
基金
日本学术振兴会;
关键词
claudins; irritable bowel syndrome; tight junction; mast cell; eosinophil; SHOWS MOLECULAR ALTERATIONS; JUNCTION SIGNALING PATHWAY; TIGHT JUNCTION; MAST-CELLS; EPITHELIAL-CELLS; CLINICAL-MANIFESTATIONS; MUCOSAL PATHOBIOLOGY; ABDOMINAL-PAIN; PERMEABILITY; JEJUNUM;
D O I
10.3164/jcbn.16-92
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Intestinal epithelial barrier function is impaired in irritable bowel syndrome patients. Claudins are highly expressed in cells with tight junctions and are involved in the intestinal epithelial barrier function. The expression pattern of tight junction proteins in diarrhea-predominant irritable bowel syndrome have not been fully elucidated. We therefore recruited 17 diarrhea-predominant irritable bowel syndrome patients and 20 healthy controls. The expression of the tight junction-related proteins was examined in the ileal, cecal, and rectal mucosa of diarrhea-predominant irritable bowel syndrome patients using real-time PCR and immunofluorescence. Claudin-2 expression was high in the ileum of diarrhea-predominant irritable bowel syndrome patients. Claudin-2 expression was the same in cecum and rectal mucosa of control and diarrhea-predominant irritable bowel syndrome patients. Similarly, the expression of clauidn-1, claudin-7, JAM-A, occludin, and ZO-1 in the ileal, cecal, and rectal mucosa did not change between control and diarrhea-predominant irritable bowel syndrome samples. Infiltration of eosinophil and mast cells in the mucosa of ileum, cecum and rectum was evaluated using immunohistochemical staining and was not affected by diarrhea-predominant irritable bowel syndrome. Claudin-2 was expressed on the apical side of villi and crypts of ileal mucosal epithelial cells. Clauidn-2 expression is upregulated in diarrhea-predominant irritable bowel syndrome patients and may contribute to the pathogenesis of this condition.
引用
收藏
页码:146 / 150
页数:5
相关论文
共 50 条
  • [1] Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome
    Dai, Cong
    Jiang, Min
    Sun, Ming-Jun
    GASTROENTEROLOGY, 2017, 152 (06) : 1629 - +
  • [2] Characterization of the fecal microbiota in patients with diarrhea predominant irritable bowel syndrome
    Carroll, Ian M.
    Shen, Xiang Jun
    Keku, Temitope O.
    Sartor, R. Balfour
    Ringel, Yehuda
    GASTROENTEROLOGY, 2008, 134 (04) : A681 - A681
  • [3] Regulation of serum microRNA expression by acupuncture in patients with diarrhea-predominant irritable bowel syndrome
    Guo, Jing
    Lu, Gao
    Chen, Lu
    Geng, Hao
    Wu, Xiaoliang
    Chen, Hao
    Li, Yang
    Yuan, Mengqian
    Sun, Jianhua
    Pei, Lixia
    ACUPUNCTURE IN MEDICINE, 2022, 40 (01) : 34 - 42
  • [4] Glutamine Restores Tight Junction Protein Claudin-1 Expression in Colonic Mucosa of Patients With Diarrhea-Predominant Irritable Bowel Syndrome
    Bertrand, Julien
    Ghouzali, Ibtissem
    Guerin, Charlene
    Bole-Feysot, Christine
    Gouteux, Melodie
    Dechelotte, Pierre
    Ducrotte, Philippe
    Coeffier, Moise
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2016, 40 (08) : 1170 - 1176
  • [5] Emerging drug for diarrhea predominant irritable bowel syndrome
    Deiana, Simona
    Gabbani, Tommaso
    Bagnoli, Siro
    Annese, Vito
    EXPERT OPINION ON EMERGING DRUGS, 2015, 20 (02) : 247 - 261
  • [6] Characterization of kynurenine pathway in patients with diarrhea-predominant irritable bowel syndrome
    Li, Pingping
    Zheng, Jimin
    Bai, Yun
    Wang, Dingxin
    Cui, Zijin
    Li, Yueqin
    Zhang, Jian
    Wang, Yuzhen
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2020, 64 : 14 - 21
  • [7] Evaluation of Crofelemer in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome Patients
    Mangel, Allen W.
    Chaturvedi, Pravin
    DIGESTION, 2008, 78 (04) : 180 - 186
  • [8] Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome Reply
    Lembo, Anthony J.
    GASTROENTEROLOGY, 2017, 152 (06) : 1630 - +
  • [9] UPREGULATED CLAUDIN-2 EXPRESSION IN INFLAMMATORY BOWEL DISEASE MAY HELP PROMOTE MUCOSAL HEALING
    Ahmad, Rizwan
    Dhawan, Punita
    Singh, Amar B.
    GASTROENTEROLOGY, 2017, 152 (05) : S965 - S965
  • [10] Does diarrhea predominant irritable bowel syndrome really exist?
    Seelis, REA
    Dohmen, W
    GASTROENTEROLOGY, 2001, 120 (05) : A755 - A755